G. Staedtler

Comparison of Occlusive and Open Application in a Psoriasis Plaque Test Design, Exemplarily Using Investigations of Mapracorat 0.1% Ointment versus Vehicle and Reference Drugs

W. Wigger‐Alberti, K. Shakery, Ragna Williams, 2017, Skin Pharmacology and Physiology.

Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial.

D. Burkhoff, F. Zannad, A. Voors, 2020, Journal of cardiac failure.

Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study.

B. Elewski, Z. Draelos, B. Havlíčková, 2013, Cutis.

A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea.

B. Elewski, Z. Draelos, J. Harper, 2015, Cutis.

Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea.

A. Menter, M. Jarratt, J. D. Del Rosso, 2010, Journal of drugs in dermatology : JDD.

Investigator-reported efficacy of azelaic acid foam 15% in patients with papulopustular rosacea: secondary efficacy outcomes from a randomized, controlled, double-blind, phase 3 trial.

S. Tyring, J. Solomon, K. Shakery, 2016, Cutis.

Patient-reported outcomes of azelaic acid foam 15% for patients with papulopustular rosacea: secondary efficacy results from a randomized, controlled, double-blind, phase 3 trial.

S. Tyring, J. Solomon, K. Shakery, 2016, Cutis.

An empirically generated responder definition for rosacea treatment

C. Gerlinger, J. Endrikat, K. Shakery, 2017, Clinical, cosmetic and investigational dermatology.

Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies

I. Macdougall, T. Akizawa, K. Iekushi, 2019, American Journal of Nephrology.